Screener
Cullinan Therapeutics, Inc. CGEM Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336717
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $78,640 | $88,332 |
| Short-term investments | 255,898 | 289,564 |
| Prepaid expenses and other current assets | 7,436 | 8,860 |
| Total current assets | 341,974 | 386,756 |
| Property and equipment, net | 263 | 421 |
| Operating lease right-of-use assets | 2,233 | 2,630 |
| Other assets | 297 | 297 |
| Long-term investments | 19,020 | 58,270 |
Item 1. Financial Statements.
FAQ
- What is Cullinan Therapeutics, Inc.'s total current assets?
- Cullinan Therapeutics, Inc. (CGEM) reported total current assets of $341.97M in Q2 2026.
- How has Cullinan Therapeutics, Inc.'s total current assets changed year-over-year?
- Cullinan Therapeutics, Inc.'s total current assets increased by 23.9% year-over-year, from $275.91M to $341.97M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s total current assets has grown at a 12.7% compound annual growth rate (CAGR), from $212.28M to $386.76M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Cullinan Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude